What Parents Should Know About Newborn Eye Ointment and Eye Infections

Shortly after birth, most New York babies receive a small ribbon of antibiotic ointment in each eye. It may briefly blur a newborn’s vision, but it isn’t routine cleaning or treatment of a visible problem.

New York requires the clinician attending the birth to administer an agent that prevents purulent conjunctivitis of the newborn, and current state guidance identifies erythromycin ointment as the standard choice.

It’s a preventive step aimed at a specific, rare, but potentially blinding infection, not a catch-all against every newborn eye problem.

This article explains what New York’s rule actually requires, what the ointment prevents (and doesn’t), what to do if you have concerns about refusal, and what eye symptoms need urgent attention.

What the Ointment Actually Prevents

Eye prophylaxis targets gonococcal ophthalmia neonatorum, caused by Neisseria gonorrhoeae, the bacterium behind gonorrhea.

This infection was once a leading cause of childhood blindness and has been almost entirely eradicated in the US through universal prophylaxis.

The numbers explain why it remains mandatory even though the disease is now rare: according to the USPSTF, without ocular prophylaxis, transmission from an infected mother to her newborn occurs in 30% to 50% of cases, and untreated infection can cause corneal scarring, perforation, and blindness as early as 24 hours after birth.

The US rate of gonococcal ophthalmia neonatorum is estimated at just 0.4 cases per 100,000 live births annually, though the USPSTF cautions this is likely underreported.

That combination, rare but fast-moving and severe, along with the reality that maternal infections aren’t always known or diagnosed in time, is the actual medical rationale for giving it to every newborn rather than only those thought to be at risk.

What It Does Not Prevent

This is the part most parents aren’t told clearly enough: erythromycin ointment does not prevent chlamydial conjunctivitis or chlamydial pneumonia in newborns.

CDC guidance is explicit on this point. Chlamydial eye infection typically becomes apparent 5 to 12 days after birth, later than gonococcal infection, and chlamydia can also cause a subacute pneumonia in infants between 1 and 3 months old.

Because the ointment offers no protection here, prenatal screening and treatment are the actual safeguard against chlamydia-related newborn infection, not a backup to the ointment but the primary defense for this specific risk.

Why Prenatal Screening Still Carries the Real Weight

CDC recommends screening all pregnant people younger than 25 for chlamydia at the first prenatal visit, along with pregnant people 25 and older who have risk factors such as a new or multiple partners or a partner with an STI.

Gonorrhea screening follows a similar age- and risk-based approach. When risk continues, CDC specifically recommends retesting in the third trimester, since a negative result earlier in pregnancy isn’t the end of the conversation if circumstances change.

For chlamydia diagnosed during pregnancy, CDC’s protocol includes prompt treatment, a test of cure around four weeks later, and retesting at three months and again near delivery when appropriate.

These two layers, prenatal screening and newborn prophylaxis, are complementary rather than redundant. Universal eye ointment exists precisely because screening, however good, doesn’t catch every case before delivery.

Why This Remains an Active Concern in New York

According to New York State Department of Health surveillance data, chlamydia remained New York’s most frequently reported STI in 2023, with 109,326 diagnoses statewide, a 5% increase from 2022. Gonorrhea diagnoses rose 6% over the same period.

Congenital syphilis, a related but distinct concern transmitted in utero rather than at delivery, saw 68 diagnoses in New York in 2023, a 33% increase from the prior year, with preliminary 2024 counts already exceeding that total.

None of this is a count of newborn eye infections specifically, and falling or rising STI diagnosis numbers in a given year don’t change whether prophylaxis is medically appropriate.

But it does show that perinatal STI prevention, of which eye ointment is one small piece, remains an active public health priority in New York rather than a historical formality.

If You Have Concerns or Want to Decline

Some parents raise questions about the ointment before delivery. Under current DOH guidance, providers are directed to explain that the treatment is mandated by regulation and to help parents understand why, sometimes with an obstetrician or pediatrician who has rapport with the family.

If a parent continues to object, the hospital is directed to document the matter with input from facility legal counsel.

Here’s the part that matters most if you’re weighing this: refusal of eye prophylaxis alone does not meet New York’s definition of child maltreatment, and a report to the Statewide Central Registry based on refusal alone will not be accepted.

This corrected older 1999 guidance that had directed providers to report refusals to Child Protective Services.

That said, there’s an important exception: if a parent has a relevant pre-existing condition, such as a current gonorrhea or chlamydia infection, and refuses treatment for the newborn in that specific context, a report may be accepted because it could place the newborn at imminent risk of harm.

If you have concerns about this treatment, the most useful step is raising them directly with your obstetric team before delivery rather than navigating it in the moment.

What Can Happen if Prophylaxis Is Missed

Missing the ointment doesn’t automatically mean a baby will develop an infection; many babies who don’t receive it remain healthy, particularly when mothers were adequately screened during prenatal care.

But it removes a protective layer, especially where a maternal infection was unknown or untreated. If gonococcal infection does develop and isn’t caught quickly, the consequences can escalate fast given how rapidly this specific infection can progress.

Newborn infections generally can move quickly in the first weeks of life; our guide on what happens when newborn infection is not treated quickly covers that broader pattern.

Symptoms Parents Should Never Ignore

Any newborn under one month who develops eye redness, marked eyelid swelling, thick or persistent discharge, or an eye that seems painful or hard to open needs prompt evaluation.

CDC guidance notes that chlamydia should specifically be considered in any infant 30 days or younger with conjunctivitis, particularly where there’s a maternal history of chlamydia, given how much later it tends to appear than gonococcal infection.

A fever alongside eye symptoms, or signs the baby seems generally unwell such as poor feeding or unusual sleepiness, is especially urgent. Don’t wait to see if mild-looking symptoms improve on their own.

What Parents Can Ask the Hospital For

If you’re concerned your baby may not have received eye ointment, you can request the hospital’s documentation.

New York hospitals must maintain accurate records and provide copies to patients or legal representatives on request; our guide on requesting your child’s medical records walks through that process. If the record shows the ointment wasn’t given, or documentation is missing, raise it with your pediatrician so they can factor it into monitoring.

When a Medical Record Review May Be Important

If your baby developed a serious eye infection and you believe missing the ointment played a role, a records review can help clarify what happened, including whether maternal STI screening was completed, whether any positive results were noted, and whether the ointment was administered on the documented timeline.

Not every documentation gap means negligence occurred; a malpractice claim requires proof that care fell below accepted standards and that the departure caused harm.

If broader vision concerns are also present, our guide on vision problems after birth injury, including CVI and PVL may be relevant, though it covers a different mechanism than infection-related vision loss.

If You’re Considering Legal Guidance

New York’s deadline for a medical malpractice claim is generally two and a half years from the malpractice under CPLR 214-a.

Because the injured person is a minor in these cases, CPLR 208 pauses that clock, but the pause cannot extend the deadline more than ten years past the date the malpractice occurred.

We’ve laid out this full framework in our guide to New York’s birth injury statute of limitations and infancy tolling rules.

Frequently Asked Questions

Is New York’s Eye Ointment Requirement the Same Rule as the Vitamin K Shot?

No, and it’s a common point of confusion since both are given shortly after birth. Eye prophylaxis (10 NYCRR § 12.2) prevents a specific eye infection and is generally given within one hour of birth. Vitamin K (10 NYCRR § 12.3) is a separate injection preventing a bleeding disorder, generally given within six hours, with some flexibility to support breastfeeding. They’re different requirements for different conditions.

Can My Baby Still Get a Gonococcal Eye Infection Even With the Ointment?

It’s possible but uncommon; erythromycin substantially reduces risk but isn’t described as 100% effective in every case, which is part of why watching for symptoms in the following days still matters regardless of whether prophylaxis was given.

If I Refuse the Ointment, Will My Baby Automatically Be Reported to Child Protective Services?

No, not based on refusal alone. Current New York guidance specifically corrected older policy that directed automatic reporting. A report may still be accepted if you have a relevant untreated infection (active gonorrhea or chlamydia) and refuse treatment for your newborn in that specific context, since that combination could place the newborn at imminent risk.

Does New York’s Rising STI Rate Mean More Babies Are Getting Eye Infections?

Not necessarily, and this shouldn’t be read that way. Rising chlamydia and gonorrhea diagnoses among adults are relevant background context for why prenatal screening and newborn prophylaxis both matter, but New York doesn’t publish a comparable, easily accessible count of newborn gonococcal eye infections specifically, so the two numbers shouldn’t be equated.

What’s the Difference Between Gonococcal and Chlamydial Newborn Eye Infection?

Gonococcal infection tends to appear faster, often within the first few days, and can progress to serious complications within 24 to 48 hours if untreated. Chlamydial infection typically appears later, around 5 to 12 days after birth, and progresses more slowly, though it still needs prompt treatment. The ointment only protects against the gonococcal type.

Summing It Up

New York’s newborn eye ointment requirement targets a rare but potentially blinding gonorrhea-related infection, and it’s a quick, low-risk layer of protection, not a judgment about any individual parent and not a replacement for prenatal STI testing and treatment.

If you have questions or concerns, the most useful step is raising them with your obstetric and pediatric team before delivery, so they can explain the requirement, the timing, and how it applies to your baby’s specific circumstances.

This article is for informational and educational purposes only. It is not a substitute for medical advice from your child’s healthcare providers or legal advice based on your family’s specific circumstances.

[Have Questions About Your Baby’s Eye Care After Birth?]
Our team can help you understand whether your child’s medical records warrant a closer look. Call 833-99-BIRTH or contact us online for a free, confidential consultation.